로딩 중…
지수 로딩 중…
ANI Pharmaceuticals, Inc.
ANIP· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$79.50-1.27%
2026-06-18
Price Chart
ANI Pharmaceuticals, Inc.+22.95%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $1.81B |
| Revenue | $924M |
| Net Income | $90M |
| Total Assets | $1.42B |
| Net Assets | $562M |
| Employees | 970 |
| Value | |
| P/E | 20.16x |
| P/B | 3.21x |
| PEG | 0.23x |
| P/S | 1.96x |
| EV/EBITDA | 7.70x |
| FCF Yield | 9.16% |
| Profitability | |
| ROE | 15.95% |
| ROA | 6.31% |
| Op. Margin | 13.38% |
| Revenue Growth | 20.46% |
| Earnings Growth | 88.07% |
| Financial Health | |
| Debt Ratio | 152.88% |
| Total Debt | $328M |
| FCF | $166M |
| Cash | $311M |
| Current Ratio | 3.12x |
| Net Debt/EBITDA | 0.07x |
| Performance | |
| 1Y Return | 22.95% |
| 1M Return | -1.02% |
| From 52W High | -20.10% |
| 1Y MDD | -28.66% |
| Trading | |
| Volume | 186,863 shares |
| Trading Value | $15M |
| Per Share | |
| EPS | $3.78 |
| BPS | $26.96 |
Company Info
CEO Mr. Nikhil Lalwani
Employees 970
HQ Baudette, United States
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally. The company provides injectables, softgel capsules, and Cortrophin gel, as well as ILUVIEN and YUTIQ products. It also manufactures oral solid dose products, semi-solids, liquids, topicals, controlled substances, and potent products. The company serves its products to national wholesalers, specialty pharmacies, retail pharmacy chains, distributors, mail order houses, group purchasing organizations, and hospitals and healthcare providers. ANI Pharmaceuticals, Inc. was incorporated in 2001 and is headquartered in Baudette, Minnesota.